Second Heart Assist Inc., founded to revolutionize the treatment of chronic heart failure (HF), focuses on developing innovative medtech solutions. The company's core mission is to enhance the lives of millions suffering from HF through its novel aortic stent pump technologies. Their primary products include the "Whisper," a catheter-based pump, and the "Freedom," a wireless-powered chronic implant, both designed to improve cardiac function and patient outcomes. The market focus is on providing advanced medical devices that offer improved solutions for heart failure patients globally.

Notable affiliations include collaborations with the Texas Heart Institute, where extensive animal testing has been conducted. Key achievements include significant progress in their product development and successful long-duration use tests. The company has garnered attention from MedTech Outlook Magazine, highlighting its innovative approach. Overall, Second Heart Assist Inc. has made a substantial impact in the medtech industry by advancing heart failure treatment technologies, aiming to improve patient quality of life and reduce healthcare costs associated with chronic HF management.